James B. Renacci sold KERYX BIOPHARMACEUTICALS INCORPORATED (KERX) (KERX)
James B. Renacci (R-OH), a U.S. Representative, has disclosed 5 trades in KERYX BIOPHARMACEUTICALS INCORPORATED (KERX) (KERX) since 2014, 2 purchases and 3 sales, worth an estimated $114K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a sale: James B. Renacci sold $1,001 - $15,000 of KERYX BIOPHARMACEUTICALS INCORPORATED (KERX) (KERX) on October 2, 2015. Since that trade, KERX is up +0.00% against the S&P 500 up +352.69%, an outperformance of -352.69%.
Across these filings, James B. Renacci has been a net seller of KERX (a buy-to-sell ratio of 0.67). Each row in the table below links to that trade and its post-trade performance versus the market.
Data updated
James B. Renacci's KERX trades vs the price
KERX is up +0.00% since James B. Renacci sold on October 2, 2015, versus +352.69% for the S&P 500.
Performance since this trade
All James B. Renacci KERX trades
Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.
James B. Renacci & KERX trading FAQ
Is it legal for James B. Renacci to trade KERYX BIOPHARMACEUTICALS INCORPORATED (KERX) (KERX) stock?
Yes. Members of Congress are allowed to trade individual stocks, including KERYX BIOPHARMACEUTICALS INCORPORATED (KERX) (KERX), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did James B. Renacci sell KERX?
James B. Renacci disclosed a sale of $1,001 - $15,000 of KERYX BIOPHARMACEUTICALS INCORPORATED (KERX) (KERX) on October 2, 2015, according to public STOCK Act filings.
How has KERX performed since James B. Renacci's trade?
Since James B. Renacci sold KERX on October 2, 2015, the stock is up +0.00%, versus +352.69% for the S&P 500 over the same period, an outperformance of -352.69%.
How many times has James B. Renacci traded KERX?
James B. Renacci has disclosed 5 KERX trades since 2014 (2 purchases and 3 sales). Every disclosed trade is listed on this page.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional KERX trades?
Quantellect tracks every disclosed congressional trade in KERYX BIOPHARMACEUTICALS INCORPORATED (KERX) (KERX) on the KERYX BIOPHARMACEUTICALS INCORPORATED (KERX) congressional trading page, which aggregates filings across all members of Congress.
James B. Renacci's KERX tradesAll congressional filings for KERYX BIOPHARMACEUTICALS INCORPORATED (KERX)James B. Renacci's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.